WorldPingSTAT
STAT+: Can buying a drug patent application be seen as a bid to prolong a monopoly?
WorldPingA drug patent case involving Amgen is being closely watched given its potential implications for pharmaceutical patent deals broadly.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT